Island Oncology

Study Shows New Approach May Have Potential to Screen for Early-Stage Ovarian Cancer

A new screening approach shows promise for the detection of ovarian cancer in postmenopausal women at average risk of the disease, early testing suggests.

The strategy uses a mathematical model that combines a patient's age and changes in blood levels of a protein called CA-125 over time to estimate risk of ovarian cancer.

In a study of more than 3,200 postmenopausal women, the approach proved feasible, with "very, very few false-positive results," says study researcher Karen Lu, MD, professor of gynecologic oncology at The University of Texas M.D. Anderson Cancer Center in Houston.

	Benjamin M. Schwartz, MD FACOG, FACS Dr. Benjamin Schwartz is a Gynecologic Oncologist and a specialist in Gynecologic Oncology and Minimally Invasive Surgery. He is a Diplomate of the American Board of Obstetrics and Gynecology.

Island Gynecologic Oncology

Our office provides comprehensive care for women with gynecological cancers. Our team is committed to treating patients with dignity, respect, and genuine concern for their well being. By combining state-of-the-art technologies, cutting edge NCI, GOG, and Industry-sponsored clinical trials, and advanced surgery techniques with a warm and comfortable atmosphere, we offer patients hope even in the face of life-threatening illnesses.

Content on this page requires a newer version of Adobe Flash Player.

Content on this page requires a newer version of Adobe Flash Player.